EKF Diagnostics Holdings plc
Company Snapshot
Founded: 1990
Entity Type: Public
Employees: 334
Region: U.S.
Revenue: $65.4 Millions
Revenue Year: 2023
Headquarter: Cardiff, U.K.
Key Geographics: U.S., Other Americas, Germany, U.K., Ireland, Rest of Europe, Russia, Middle East and Africa, China, Rest of Asia, Oceania
Corporate Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, CF64 2EZ U.K. Tel. +44-0-2920-710570 www.ekfdiagnostics.com
Company Overview
EKF Diagnostics offers reagents and diagnostic instruments for the IVD market. The company’s PoC line includes glucose analyzers, HbA1c analyzers and hemoglobin analyzers. The company’s Central Laboratory business segment includes product lines for small and large laboratories. DiaSpect is its new handheld hemaglobin analyzer that connects to EKF Link, the company’s PoC middleware.
Financial Highlights (FY 2023)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
EKF Diagnostics Holdings plc In Reports
EKF Diagnostics Holdings plc In News
Applications/End User Industries
- Biotechnology
- Diagnostics
- Healthcare
- Medical Practitioners
- Life Sciences
- In-Vitro Diagnostics
- Hematology
- Therapeutic Enzymes
- Enzyme Fermentation
- Diabetes
BCC Research Beacon 